The global biopsy devices market size was USD 2.17 billion in 2021 and is expected to register a CAGR of 7.1% during the forecast period. Rising prevalence of life-threatening diseases such as cancer, escalating demand for minimally invasive surgical procedures, rise in initiatives being undertaken by governments and leading healthcare organizations to raise cancer awareness globally, and growing demand for early cancer diagnosis and management are some of the most critical factors increasing the growth of this market.
In addition, growing burden of chronic and infectious diseases, increasing patient population, rising use of advanced imaging technologies, such as Magnetic Resonance Imaging (MRI) and Computed Tomography (CT), in diagnostic procedures, and rising expenditure on healthcare services are other factors expected to provide impetus to the global market growth in the coming years. Technological advancements in biopsy devices over the past decade and emergence of cutting-edge technologies including stereotactic-guided biopsies, ultrasound-guided biopsies, vacuum-assisted biopsies, and 3D optical biopsies have led to massive adoption of biopsy devices worldwide. Moreover, rising awareness about the advantages of biopsy procedures, such as lesser pain and scarring, smaller incisions, quicker recovery, and cost-effectiveness, is expected to further boost demand for biopsy devices during the forecast period.
Request a Sample@ https://www.qyresearchmedical.com/sample/119142
Biopsy is a medical examination process that involves removal of tissue from the affected area of body to study the cause of a disease. A biopsy is performed in various ways; some biopsies use a specific type of needle to remove the tissue, while others involve surgical intervention for the same. Removal of tissue is usually done by inserting a needle into the body percutaneously. Biopsies are performed using advanced imaging techniques including ultrasound, magnetic resonance imaging, computed tomography, and x-ray. They are intended to detect various types of cancers, peptic ulcers, kidney disorders, liver inflammation, and specific infections. Different procedures carried out to obtain biopsy samples include punch biopsy for diagnosis of skin conditions, needle biopsy guided by ultrasound or CT scan, endoscopic biopsy, fine needle aspiration, and minimally invasive excisional and incisional biopsies. Biopsy devices also come with various safety features such as safety scalpels, waste disposal, and label systems that help reduce medication errors and make clinical setting much safer for both patients and clinicians.
Global Biopsy Devices Market: Dynamics
Drivers: Increasing use of biopsy devices in breast cancer diagnosis is a major market growth propeller
Widespread use of biopsy devices in diagnosis and treatment of breast cancer is one of the most significant factors propelling the global market growth. Breast cancer is one of world’s most prevalent types of cancer. According to the World Health Organization (WHO), the condition is diagnosed in around 2.1 million women around the world each year. However, the disease is now somewhat preventable due to rapid advancements in medical technology. Rising awareness about breast cancer and growing need for early and accurate diagnosis are further expected to drive demand for biopsy procedures.
Restraints: Risks associated with surgical biopsies are predicted to restrict market growth
Several risks and complications associated with surgical biopsies are expected to significantly restrain the global biopsy devices market growth in the forthcoming years. Commonly observed side-effects of a surgical biopsy are bruising, excessive bleeding or hemorrhage, pain and numbness in surgical site, severe infections, and protracted healing of wounds. These surgeries often result in puncture damage to the surrounding tissue or organs. Moreover, they can lead to changes in the size and shape of breast due to complications in the procedure.
Global Biopsy Devices Market: Product Type Outlook
Based on the product type, the global biopsy devices market is segmented into needle-based biopsy instruments, manual and robotic biopsy guidance systems, biopsy forceps, procedure trays, localization wires, and others. The needle-based biopsy instruments segment is expected to reach highest revenue share over the forecast years, owing to the extensive use of these instruments in diagnosis of cancerous tumors in breasts, lungs, and kidneys, and technological advancements in these products. Rising popularity of minimally invasive diagnostic solutions and growing preference for needle-based biopsies are other key factors expected to bolster the growth of this segment.
Global Biopsy Devices Market: Regional Overview
The global biopsy devices market comprises several leading regions including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The North America biopsy devices market is predicted to register the fastest growth in revenue over the forecast period. The regional market is expected to gain significant traction due to rising prevalence of chronic and infectious diseases including cancer, rise in biopsy procedures, and growing adoption of advanced products such as vacuum-assisted biopsy systems. Increasing government initiatives to spread cancer awareness, rising need for early cancer screening and treatment, and presence of state-of-the-art healthcare infrastructure across the region are other crucial factors responsible for market growth in North America.
Companies Profiled in the Report:
Medtronic Plc, Argon Medical Devices, Inc., Becton Dickinson and Company, B. Braun Melsungen AG, Boston Scientific Corporation, Fujifilm Holdings Corp., Cardinal Health, Inc., Danaher Corporation (Leica Microsystem), Hologic, Inc., Devicor Medical Products, Inc., Cook Medical, Inc., Olympus Corporation, INRAD, Inc., and C. R. Bard, Inc. are among the most prominent companies operating in the global biopsy devices market.
- In January 2021, a team of researchers from the Corpuscular Physics Institute’s Gamma and Neutron Spectroscopy Group developed a novel device that enables real-time guided biopsy. The new device is said to find significant application in cancer diagnosis and treatment and makes the treatment process personalized and highly cost-effective.
- In October 2020, GE Healthcareannounced the launch of its new Serena Bright biopsy technology in the U.S. The new technology, which is touted as the first-ever contrast-enhanced guided biopsy solution in the healthcare industry, is specifically designed for breast cancer diagnosis and treatment.
Global Biopsy Devices Market Segmentation:
For the purpose of this report, the global biopsy devices market is segmented based on product type, imaging technique, application, end-use, and region:
Biopsy Devices Market Report Scope
Segments covered By Product Type, Imaging Technique, Application, Regional Outlook
By Type Outlook
Needle-based Biopsy Instruments
Core Biopsy Devices
Core Biopsy Guns
Core Biopsy Needles
Vacuum-assisted Biopsy Devices
Vacuum-assisted Biopsy Systems
Vacuum-assisted Biopsy Needles
Manual and Robotic Biopsy Guidance Systems
Others (brushes, punches, curettes, etc.)
By Imaging Technique
Diagnostic and Imaging Centers
Academic & Research Institutes
Middle East & Africa
Buy quantitative research Report at discounted price – USD 1500 https://www.qyresearchmedical.com/report/checkout/119142/1500
You can place an order or ask any questions, please feel free to contact email@example.com | +1 9197 992 333
QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover North America, Europe, Latin America, Middle East and Africa, Asia- Pacific.
For Latest Update Follow Us: